Example of Infectious Disease Reports format
Recent searches

Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format Example of Infectious Disease Reports format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Infectious Disease Reports — Template for authors

Categories Rank Trend in last 3 yrs
Infectious Diseases #177 of 288 up up by 2 ranks
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 98 Published Papers | 232 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 27/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

PLOS

Quality:  
High
CiteRatio: 7.1
SJR: 1.99
SNIP: 1.774
open access Open Access

American Chemical Society

Quality:  
High
CiteRatio: 6.0
SJR: 1.324
SNIP: 1.029
open access Open Access
recommended Recommended

Oxford University Press

Quality:  
High
CiteRatio: 9.1
SJR: 2.124
SNIP: 1.646
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 6.5
SJR: 1.812
SNIP: 1.485

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

2.4

55% from 2019

CiteRatio for Infectious Disease Reports from 2016 - 2020
Year Value
2020 2.4
2019 5.3
2018 3.1
2017 1.8
2016 1.9
graph view Graph view
table view Table view

0.487

40% from 2019

SJR for Infectious Disease Reports from 2016 - 2020
Year Value
2020 0.487
2019 0.813
2018 0.774
2017 0.66
2016 0.476
graph view Graph view
table view Table view

0.666

45% from 2019

SNIP for Infectious Disease Reports from 2016 - 2020
Year Value
2020 0.666
2019 1.202
2018 0.855
2017 0.717
2016 0.406
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 55% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has decreased by 40% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 45% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Infectious Disease Reports

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

PagePress Publications

Infectious Disease Reports

Approved by publishing and review experts on SciSpace, this template is built as per for Infectious Disease Reports formatting guidelines as mentioned in PagePress Publications author instructions. The current version was created on 26 Jun 2020 and has been used by 589 authors to write and format their manuscripts to this journal.

Infectious Diseases

Medicine

i
Last updated on
26 Jun 2020
i
ISSN
2036-7430
i
Impact Factor
Low - 0.154
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
Vancouver
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Blonder GE, Tinkham M, Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent con-version. Phys Rev B. 1982;25(7):4515–4532. Available from: 10.1103/PhysRevB.25.4515.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.4081/IDR.2016.6570
Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination.
Mario C. Raviglione1, Giorgia Sulis2

Abstract:

Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide, accounting for about 9.6 million new cases and 1.5 million deaths annually. The poorest and socially excluded groups carry the largest burden of disease, which makes it essential to properly address the social determinants of health through poverty red... Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide, accounting for about 9.6 million new cases and 1.5 million deaths annually. The poorest and socially excluded groups carry the largest burden of disease, which makes it essential to properly address the social determinants of health through poverty reduction measures and targeted interventions on high-risk populations. The spread of multidrug-resistance TB requires special attention and highlights the need to foster research on TB diagnostics, new drugs and vaccines. Although many advances have been made in the fight against TB over the last twenty years, a lot is still needed to achieve global elimination. The new end-TB strategy that was first launched in 2014 by the World Health Organization, is fully in line with the seventeen Sustainable Development Goals that came into effect since January 2016 and sets ambitious goals for the post-2015 agenda. A 90% reduction in TB-related mortality and an 80% decline in TB incidence within 2030 as well as the abolition of catastrophic expenditures for TB-affected people are the main targets of this strategy. Strong government commitment and adequate financing from all countries together with community engagement and appropriate investments in research are necessary in order to reach these objectives. read more read less

Topics:

Social determinants of health (52%)52% related to the paper
View PDF
202 Citations
open accessOpen access Journal Article DOI: 10.4081/IDR.2020.8543
National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management.

Abstract:

On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pand... On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The "L. Spallanzani" National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. read more read less
View PDF
152 Citations
open accessOpen access Journal Article DOI: 10.4081/IDR.2016.6568
Tuberculosis Biomarkers: From Diagnosis to Protection
Delia Goletti, Elisa Petruccioli, Simone A. Joosten1, Tom H. M. Ottenhoff1

Abstract:

New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools for diagnosis and new biomarkers are required to evaluate both pathogen and host key elements of the response to infection. Non-sputum based diagnostic tests, biomarkers predictive of adequate responsiveness to treatment, and biomarkers... New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools for diagnosis and new biomarkers are required to evaluate both pathogen and host key elements of the response to infection. Non-sputum based diagnostic tests, biomarkers predictive of adequate responsiveness to treatment, and biomarkers of risk of developing active TB disease are major goals. Here, we review the current state of the field. Although reports on new candidate biomarkers are numerous, validation and independent confirmation are rare. Efforts are needed to reduce the gap between the exploratory up-stream identification of candidate biomarkers, and the validation of biomarkers against clear clinical endpoints in different populations. This will need a major commitment from both scientists and funding bodies. read more read less

Topics:

Biomarker discovery (59%)59% related to the paper
View PDF
138 Citations
open accessOpen access Journal Article DOI: 10.4081/IDR.2020.8516
Covid-19 R0: Magic number or conundrum?

Abstract:

There is an increasing concern about COVID-19 worldwide. This is a new emerging infectious disease caused by a novel coronavirus (SARS-CoV-2), which recently broke out from the Chinese city of Wuhan and has quickly spread in China, with sporadic cases in each continent.1 At the date of February 20th, 2020, SARS-CoV-2 caused 7... There is an increasing concern about COVID-19 worldwide. This is a new emerging infectious disease caused by a novel coronavirus (SARS-CoV-2), which recently broke out from the Chinese city of Wuhan and has quickly spread in China, with sporadic cases in each continent.1 At the date of February 20th, 2020, SARS-CoV-2 caused 74 675 infections in China with 2 121 deaths, and 1 073 infections in 26 countries with 8 deaths outside China.1 COVID-19 represents the third coronavirus-associated epidemic to emerge from a species leap from wild animals to humans, after Severe Acute Respiratory Syndrome (SARS) in 2003, and the Middle East Respiratory Syndrome (MERS) in 2012.2,3 SARS-CoV-2 Often causes a respiratory disease, similar to SARS and MERS, ranging from mild upper respiratory illness to a severe interstitial pneumonia, also requiring intensive care.4,5 One of the most discussed issues about COVID-19 is its basic reproduction number (R0). Public opinion and mass media are increasingly focusing on this epidemiological value, often alarming about the spreading potential of this novel infection, defining R0 as a “fatal number”: the more it increases, the greater is the risk for the population, including higher mortality potential. On the other hand, the scientific community has not given a definite and sound response about the real epidemiological potential of COVID-19, to date. Scientists are currently debating about the actual reproductive number of COVID-19 and it is not hard to find sensationalistic statements about the R0 and its impact on the pandemic COVID-19 potential. Indeed, since COVID-19 broke out, several published study aiming to forecast its epidemic trend, have estimated different R0 values, often much higher than that of SARS and MERS. R0 is the average number of secondary infections produced by an infectious case in a population where everyone is susceptible and it is used to measure the transmission potential of a communicable disease.6 When R0 is >1, it means that each individual affected by a transmittable disease is expected to infect a number of subjects that increase exponentially with the increase of the R0 value and the disease is expected to spread through the susceptible population. Conversely, when R0 is <1 each case transmits the disease to one or less than one individual and the disease is expected to die out in the population.6 Although the concept of R0 is very intuitive, its calculation is based on complex models and may lead to misinterpretations, especially for what concerns the real weight that R0 has on the spreading of an infectious disease and on the feasibility of controlling an epidemic.6 The basic reproductive number (R0) of COVID-19 has been initially estimated by the World Health Organization (WHO) to range between 1.4 and 2.5, as declared in the statement regarding the outbreak of SARS-CoV-2, dated 23th January 2020.7 However, several published studies aimed to precisely estimate the COVID-19 R0. A recent review written by Liu et al. compared 12 studies published from the 1st of January to the 7th of February 2020 which have estimated the R0 for COVID19, finding a range of values between 1.5 and 6.68.8 The authors of the review calculated the mean and the median of R0 estimated by the 12 studies and they found a final mean and median value of R0 for COVID-19 of 3.28 and 2.79, respectively, with an interquartile range (IQR) of 1.16.8 According to these findings, the COVID-19 R0 would exceed the reproductive number estimated for SARS.9 The reasons behind a low level of accordance between studies attempting to estimate the R0 are complex and can be attributed to 3 possible reasons: i) different variables considered; ii) different methods for modeling; and iii) different estimation procedures.9 Firstly, R0 is not an intrinsic variable of the infectious agent, but it is calculated through at least three parameters: the duration of contagiousness; the likelihood of infection per contact between; and the contact rate, along with economical, social and environmental factors, that may vary among studies aimed to estimate the R0. More, the use of different models for the estimation of R0 may play a role in the discrepancies observed among the studies on COVID-19. In fact, according to Liu’s findings, the studies using mathematical methods produce estimates that are higher than stochastic and statistic models in determining COVID-19 R0.8 It must be noted that the estimation of R0 assumes that the number of secondary infections produced by a single case has no variations.9 However, super-spreading events, in which a single individual, not necessarily strongly symptomatic, may infect a wide number of subjects, as occurred in the past with SARS and MERS, may occur.10 Recently, a British businessman with COVID-19 has been alleged to transmit the infection to 11 people in a French chalet.11 Therefore, the models used to estimate the R0 cannot fully consider the large heterogeneity in space, transmissibility, and susceptibility of an infection. Additionally, the basic reproductive number is constantly modified during an epidemic by the control measures adopted to reduce the fundamental coefficient of R0, namely: i) the duration of contagiousness; ii) the likelihood of infection per contact; and iii) the contact rate.12 One effective measure is quarantine. During SARS epidemic, several countries introduced the use of mass quarantine for all individuals suspected of having had contact with a confirmed SARS case. These coordinated global efforts were remarkably effective at curtailing the spread of the disease, and this strategy was effective, together with isolation of infected patients and public health measures to contain the epidemic and avoiding SARS reemergence. Another important value that has not received sufficient attention to date is the control reproductive number (Rc) that is the value of R in the presence of control measures. If Rc can be sustained at values below one, then the disease will eventually Infectious Disease Reports 2020; volume 12:8516 read more read less

Topics:

Magic number (chemistry) (52%)52% related to the paper
View PDF
117 Citations
open accessOpen access Journal Article DOI: 10.4081/IDR.2013.S1.E6
Pathogenesis of HIV infection
Hassan M. Naif1

Abstract:

Over the past three decades of intense research on the contribution of viral and host factors determining the variability in HIV-1 infection outcome, HIV pathogenesis is still a fascinating topic that requires further study. An understanding of the exact mechanism of how these factors influencing HIV pathogenesis is critical ... Over the past three decades of intense research on the contribution of viral and host factors determining the variability in HIV-1 infection outcome, HIV pathogenesis is still a fascinating topic that requires further study. An understanding of the exact mechanism of how these factors influencing HIV pathogenesis is critical to the development of effective strate- gies to prevent infection. Significant progress has been made in identifying the role of CCR5 (R5) and CXCR4 (X4) HIV strains in disease progression, particularly with the persistence of R5 HIV-1 strains at the AIDS stage. This indicates that R5 strains are as fit as X4 in causing CD4+ T cell depletion and in contribution to disease outcome, and so questions the prerequisite of the shift from R5 to X4 for disease progression. In contrast, the ability of certain HIV strains to readily use CXCR4 for infection or entry into macrophages, as the case with viruses are homozygous for tropism by CCR5delta32. This raises another major paradox in HIV pathogenesis about the source of X4 variants and how do they emerge from a relatively homogeneous R5 viral population after transmission. The interactions between viral phenotypes, tropism and co-receptor usage and how they influence HIV pathogenesis are the main themes addressed in this review. A better understanding of the viral and host genetic factors involved in the fitness of X4 and R5 strains of HIV-1 may facilitate development of specific inhibitors against these viral populations to at least reduce the risk of disease progression. read more read less

Topics:

Viral pathogenesis (65%)65% related to the paper, Tropism (51%)51% related to the paper, Transmission (medicine) (51%)51% related to the paper, Population (51%)51% related to the paper, Acquired immunodeficiency syndrome (AIDS) (51%)51% related to the paper
View PDF
114 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Infectious Disease Reports.

It automatically formats your research paper to PagePress Publications formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Infectious Disease Reports format uses Vancouver citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Infectious Disease Reports in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Infectious Disease Reports guidelines and auto format it.

2. Do you follow the Infectious Disease Reports guidelines?

Yes, the template is compliant with the Infectious Disease Reports guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Infectious Disease Reports?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Infectious Disease Reports citation style.

4. Can I use the Infectious Disease Reports templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Infectious Disease Reports.

5. Can I use a manuscript in Infectious Disease Reports that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Infectious Disease Reports that you can download at the end.

6. How long does it usually take you to format my papers in Infectious Disease Reports?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Infectious Disease Reports.

7. Where can I find the template for the Infectious Disease Reports?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Infectious Disease Reports's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Infectious Disease Reports's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Infectious Disease Reports an online tool or is there a desktop version?

SciSpace's Infectious Disease Reports is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Infectious Disease Reports?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Infectious Disease Reports?”

11. What is the output that I would get after using Infectious Disease Reports?

After writing your paper autoformatting in Infectious Disease Reports, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Infectious Disease Reports's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Infectious Disease Reports?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Infectious Disease Reports. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Infectious Disease Reports?

The 5 most common citation types in order of usage for Infectious Disease Reports are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Infectious Disease Reports?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Infectious Disease Reports's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Infectious Disease Reports in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Infectious Disease Reports Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Infectious Disease Reports formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template